⚖️ SCOTUS Pauses Mife Ruling — The Fight Isn't Over

The U.S. Supreme Court extended the pause on restrictions to mifepristone access by mail and at pharmacies — but this is not a victory. The case continues, and access is still at risk. Help us prepare for what comes next.

$
close up of pills in a packet
Skip to content
Home
  1. Court Cases
    1. Landmark Cases
    2. All Cases
    3. Amicus Work
  2. Policy and Resources
    1. Maps & Tools
    2. Explainers
    3. Insights
    4. Publications
    5. Policy
    6. Resources
  3. Issues
    1. Abortion
    2. Maternal Health
    3. Adolescent Health and Rights
    4. Assisted Reproduction
    5. Contraception
    6. Humanitarian Settings
  4. Regions
    1. Global Advocacy
    2. Africa
    3. Asia
    4. Europe
    5. Latin America & the Caribbean
    6. United States
      1. U.S. Advocacy
  5. News
    1. Features & Stories
    2. Press Room
    3. News
  6. About
    1. Impact
    2. Leadership & Staff
    3. Annual Reports & Financials
    4. Corporate Engagement
    5. Pro Bono Program
    6. Diversity, Equity, and Inclusion
    7. Careers
    8. Contact Us
  1. Get Involved
    1. Ways to Give
    2. Events
  2. Donate
  1. Donate
Menu Close

Policy & Resources

TN COVID-19 Complaint

  • Case Document
April 13, 2020
1 min. read
  • https://reproductiverights.org/resources/tn-covid-19-complaint/
  • Share this page on Twitter
  • Share this page on LinkedIn

Downloads

Download Attachment

Fuel the Fight for Reproductive Rights

Your donation allows us to defend reproductive rights, change policies, and amplify voices around the globe.

$
Home
  1. Abortion Laws by State
  2. World’s Abortion Laws
  3. Press Room
  4. Publications
  5. Careers
  6. Ways to Give
  7. Privacy Policy
  8. Gift Acceptance Policy
  9. Contact Us

Knowledge is Power.
Sign up for newsletter updates.

© Center for Reproductive Rights (2025–2026)

  • Facebook
  • LinkedIn
  • YouTube
  • Instagram
Press enter to search

A Win Today. A Fight Still Ahead.

SCOTUS’ ruling keeps mifepristone access intact — but Louisiana v. FDA isn't over. The anti-abortion movement isn't stopping. Learn what the ruling means and what comes next.

GET THE LATEST Press release to the LA vs FDA mifepristone case

Mobile Menu Overlay

  1. Court Cases
    • Landmark Cases
    • All Cases
    • Amicus Work
  2. Policy and Resources
    • Maps & Tools
    • Explainers
    • Insights
    • Publications
    • Policy
    • Resources
  3. Issues
    • Abortion
    • Maternal Health
    • Adolescent Health and Rights
    • Assisted Reproduction
    • Contraception
    • Humanitarian Settings
  4. Regions
    • Global Advocacy
    • Africa
    • Asia
    • Europe
    • Latin America & the Caribbean
    • United States
      • U.S. Advocacy
  5. News
    • Features & Stories
    • Press Room
    • News
  6. About
    • Impact
    • Leadership & Staff
    • Annual Reports & Financials
    • Engagement Programs
    • Corporate Engagement
    • Pro Bono Program
    • Diversity, Equity, and Inclusion
    • Careers
    • Contact Us
  7. Get Involved
    • Ways to Give
    • Events
  1. Donate